Public Health Management Corporation, Philadelphia, PA.
Columbia University School of Nursing, New York, New York.
Nurs Outlook. 2021 Sep-Oct;69(5):848-855. doi: 10.1016/j.outlook.2021.03.012. Epub 2021 May 12.
Advanced practice registered nurses (APRNs) are increasingly caring for individuals with opioid use disorder. Advances have been made to increase APRN education, outreach, and prescribing privileges, but as demand for medication for opioid use disorder (MOUD) grows, evidence suggests that policy and care barriers inhibit the ability of APRNs to support MOUD.
This paper highlights the significant challenges of expanding access to buprenorphine prescribing by APRNs.
Barriers and recommendations were derived from the culmination of literature review, expert consensus discussions among a diverse stakeholder panel including patient representatives, and feedback from community webinars with care providers.
We provide an overview of existing care barriers, promising practices, and proposed recommendations to enhance the care of individuals and communities with opioid use disorder.
越来越多的高级执业注册护士（APRNs）正在照顾阿片类药物使用障碍患者。为了增加 APRN 的教育、外展和处方权限，已经取得了一些进展，但随着对阿片类药物使用障碍（MOUD）药物的需求增加，有证据表明政策和护理障碍抑制了 APRN 支持 MOUD 的能力。
本文强调了扩大 APRN 开处丁丙诺啡处方机会所面临的重大挑战。
通过文献回顾、包括患者代表在内的多元化利益相关者小组的专家共识讨论以及与护理提供者进行的社区网络研讨会的反馈，得出了障碍和建议。
我们提供了对现有护理障碍、有希望的实践以及增强对阿片类药物使用障碍患者和社区护理的建议的概述。
